Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VPD specializes in acquiring and developing promising drug candidates from late pre-clinical through early clinical stages. The company advances these assets to clinical proof-of-concept—typically Phase 2—before seeking out-license or sale opportunities. Notable results include advancing peptide-based therapeutics for NASH and participating in the formation of Vitesse Biologics for antibody/protein therapies[5][7].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VPD Partners.